Dark

LIVN
LivaNova PLC
stock NASDAQ

At Close

Jul 3, 2025 12:59:58 PM EDT

46.07USD-0.022%(-0.01)243,250

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 3, 2025 9:09:30 AM EDT

45.71USD-0.803%(-0.37)600

After-hours

Jul 2, 2025 4:00:30 PM EDT

46.08USD-0.076%(-0.04)0

OverviewOptionsHistoricalExchangesShortsNews

Dec 3, 2021

10:17AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021 Benzinga

05:32AM EST Goldman Sachs Initiates Coverage On LivaNova with Buy Rating, Announces Price Target of $108 Benzinga

Dec 2, 2021

09:10AM EST LivaNova To Present Scientific Data On VNS Therapy For Drug-Resistant Epilepsy At American Epilepsy Society 2021 Annual Meeting On Dec. 3-7 Benzinga

Dec 1, 2021

09:15AM EST LivaNova To Present Scientific Data On VNS Therapy For Difficult-To-Treat Depression At 4th International Brain Stimulation Conference On Dec. 6-9 Benzinga

09:00AM EST LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference Business Wire

Nov 12, 2021

05:47PM EST LivaNova Comments on Decision by Court of Appeal of Milan Business Wire

Nov 8, 2021

09:08AM EST LivaNova Announces 2021 Virtual Investor Day Dec. 7 Benzinga

Nov 3, 2021

12:59PM EDT Needham Maintains Buy on LivaNova, Raises Price Target to $120 Benzinga

09:13AM EDT LivaNova Q3 EPS $0.68 Beats $0.44 Estimate, Sales $253.20M Beat $245.27M Estimate Benzinga

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

Sep 14, 2021

07:05AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Paul Buckman to its Board of Directors, effective September 10, 2021. Mr. Buckman will serve as Chair of the Companys Audit Committee and as a member of its Compensation and Nominating & Governance Committees. GlobeNewswire Inc

Aug 20, 2021

07:52AM EDT 10 Biggest Price Target Changes For Friday Benzinga

06:00AM EDT Needham Maintains Buy on LivaNova, Raises Price Target to $117 Benzinga

Aug 17, 2021

09:30AM EDT Baird Maintains Outperform on LivaNova, Raises Price Target to $105 Benzinga

Aug 16, 2021

05:36PM EDT 13F From David Einhorn's Greenlight Shows New Stake In LivaNova Benzinga

Aug 4, 2021

11:07AM EDT Looking into LivaNova's Return on Capital Employed Benzinga

Aug 2, 2021

04:51PM EDT LivaNova Announces $300M Common Stock Offering Benzinga

Jul 28, 2021

06:08AM EDT LivaNova Sees FY21 Adj. EPS $1.60-$1.90 vs $1.65 Est. Benzinga

06:07AM EDT LivaNova Q2 Adj. EPS $0.52 Beats $0.33 Estimate, Sales $264.50M Beat $246.17M Estimate Benzinga

04:27AM EDT Earnings Scheduled For July 28, 2021 Benzinga

Jul 27, 2021

11:13AM EDT LivaNova's Earnings: A Preview Benzinga

Jul 26, 2021

07:17AM EDT What Does LivaNova's Debt Look Like? Benzinga

Jul 20, 2021

11:23AM EDT UPDATE: Needham On LivaNova Upgrade: Firm Highlights RECOVER Study As Major Potential Catalyst With A Potential Earlier Indication Of Success Than Expected; Expects ANTHEM-HFrEF Heart Failure Pivotal Trial To Cross 400 Patients With Follow-Up Data In 1Q21 Benzinga

10:14AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 Benzinga

05:20AM EDT Needham Upgrades LivaNova to Buy, Announces $93 Price Target Benzinga

Jun 15, 2021

09:02AM EDT LivaNova Says Receives FDA Approval For Clinical Study To Evaluate Aura6000 System To Treat Obstructive Sleep Apnea Benzinga

Jun 2, 2021

07:37AM EDT Piper Sandler Maintains Overweight on LivaNova, Lowers Price Target to $98 Benzinga

07:05AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the position of Vice President of Sales & Marketing, North America, effective June 1, 2021. GlobeNewswire Inc

Apr 28, 2021

07:14AM EDT Recap: LivaNova Q1 Earnings Benzinga

04:15AM EDT Earnings Scheduled For April 28, 2021 Benzinga

Apr 26, 2021

09:15AM EDT LivaNova, Verily Report First Patient Enrolled In Study To Evaluate Treatment Effectiveness For Patients Living With Depression Benzinga

Apr 20, 2021

09:01AM EDT LivaNova Receives FDA 510(k) Clearance For B-Capta Blood-Gas Monitoring System Integrated Into The S5 Heart-Lung Machine Benzinga

Apr 19, 2021

09:12AM EDT LivaNova Says Has Randomized 300ty Patient In ANTHEM-HFrEF Pivotal Study Benzinga

09:00AM EDT LivaNova Achieves Clinical Milestone in Heart Failure Program Business Wire

Apr 13, 2021

08:33AM EDT 10 Biggest Price Target Changes For Tuesday Benzinga

06:39AM EDT Piper Sandler Maintains Overweight on LivaNova, Raises Price Target to $92 Benzinga

Mar 17, 2021

07:05AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Sherrie Perkins, effective March 15, 2021. GlobeNewswire Inc

Mar 3, 2021

03:58PM EST 'Permira bids for $3.7bn medical device maker LivaNova' -Financial Times Report Benzinga

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021 Benzinga

06:28AM EST Berenberg Downgrades LivaNova to Hold, Announces $84 Price Target Benzinga

Feb 24, 2021

07:10AM EST LivaNova: Q4 Earnings Insights Benzinga

06:22AM EST LivaNova Sees FY21 EPS $1.40-$1.90 Vs. $1.98 Est. Benzinga

06:21AM EST LivaNova Q4 EPS $0.71 Beats $0.66 Estimate, Sales $269.60M Beat $268.83M Estimate Benzinga

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Jan 5, 2021

10:11AM EST Benzinga's Top Upgrades, Downgrades For January 5, 2021 Benzinga

05:35AM EST Needham Downgrades LivaNova to Hold Benzinga

Dec 3, 2020

05:06AM EST Entities Funded And Controlled By Gyrus To Acquire LivaNova Heart Valve Business RTTNews

Nov 10, 2020

09:00AM EST LivaNova Wins Department Of Defense Contract Titled 'SenTiva Generator System' Benzinga

Oct 29, 2020

07:57AM EDT Recap: LivaNova Q3 Earnings Benzinga

06:28AM EDT LivaNova Sees FY20 Adj. EPS $1.15-$1.35 vs $1.18 Est. Benzinga

06:27AM EDT LivaNova Q3 Adj. EPS $0.38 Beats $0.21 Estimate, Sales $240.10M Beat $218.55M Estimate Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 12, 2020

05:18PM EDT LivaNova Confirms Receipt Of Letter From PrimeStone Capital (Full Letter) Benzinga

09:09AM EDT LivaNova To Present New Data At European Association For Cardio-Thoracic Surgery Annual Meeting Demonstrating Benefits Of Perceval Sutureless Valve Benzinga

Sep 2, 2020

10:21AM EDT Benzinga's Top Upgrades, Downgrades For September 2, 2020 Benzinga

06:04AM EDT Baird Initiates Coverage On LivaNova with Outperform Rating, Announces Price Target of $55 Benzinga

Jul 29, 2020

01:04PM EDT Needham Maintains Buy on LivaNova, Lowers Price Target to $68 Benzinga

07:18AM EDT LivaNova: Q2 Earnings Insights Benzinga

04:04AM EDT Earnings Scheduled For July 29, 2020 Benzinga

Jul 16, 2020

09:09AM EDT LivaNova Reports Commercial Launch Of Perceval Plus Aortic Heart Valve In Europe Benzinga

document.getElementById("YzWm61").onerror = function(){this.style.display='none';}; .dark-mode .J2Rs04{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .J2Rs04{ color: #333333; background-color: white; border: 2px solid #333333; }LIVNLivaNova PLCstock NASDAQ

LIVN
LivaNova PLC
stock NASDAQ